OTCM OTC Markets Group Cl A

Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum March 26th

Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum March 26th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

TORRANCE, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB:EMMA), a leader in sickle cell disease treatment, today announced that Dr. Yutaka Niihara, M.D., M.P.H., Chairman and Chief Executive Officer, and Jay Sherwood, Chief Financial Officer, will present live at LifeSciencesInvestorForum.com on March 26th.

DATE: March 26, 2020  

TIME: 11:00am ET

LINK:

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at .

About Emmaus Life Sciences

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. Its FDA-approved Endari® (prescription grade L-glutamine oral powder) is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. For more information, please visit .

About Life Sciences Investor Forum

Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACTS:

Emmaus Life Sciences, Inc.

Joseph (Jay) C. Sherwood III

Chief Financial Officer

(310) 214-0065, Ext. 3005

Life Sciences Investor Forum

John M. Viglotti

SVP Corporate Services, Investor Access

(212) 220-2221

EN
23/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OTC Markets Group Cl A

 PRESS RELEASE

OTC Markets Group Welcomes Zoomcar Holdings, Inc. to OTCQX

OTC Markets Group Welcomes Zoomcar Holdings, Inc. to OTCQX NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: ZCAR) (“Zoomcar”), leading marketplace for self-drive car sharing in India, has qualified to trade on the OTCQX® Best Market. Zoomcar previously traded on NASDAQ. Zoomcar begins trading today on OTCQX under the symbol “ZCAR.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . Trading on the OTCQX Market offers c...

 PRESS RELEASE

OTC Markets Group Welcomes Black Swan Graphene Inc. to OTCQX

OTC Markets Group Welcomes Black Swan Graphene Inc. to OTCQX NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (“Black Swan”) (TSX-V: SWAN; OTCQX: BSWGF), a company focused on the large-scale production and commercialization of patented high-performance and low-cost graphene products, has qualified to trade on the OTCQX® Best Market. Black Swan upgraded to OTCQX from the OTCQB® Venture Market. Black Swan begins trading today on OTCQX under the symbol “BSWGF.” U.S. investors can...

 PRESS RELEASE

OTC Markets Group Reports First Quarter 2025 Financial Results Deliver...

OTC Markets Group Reports First Quarter 2025 Financial Results Delivering Revenue and Operating Income Growth First Quarter 2025 Highlights: Gross revenues of $30.4 million for the quarter, up 10% versus the prior year periodOperating income of $7.3 million for the quarter, up 9% versus the prior year periodOperating profit margin of 24.7%, versus 25.0% for the prior year periodNet income of $6.0 million, up 1% versus the prior year period, and quarterly diluted GAAP EPS of $0.50, up 2% Total cash returned to shareholders during the quarter of $5.1 million, comprised of dividends of $2.2...

 PRESS RELEASE

OTC Markets Group Welcomes Steel Partners Holdings L.P. to OTCQX

OTC Markets Group Welcomes Steel Partners Holdings L.P. to OTCQX NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced . (OTCQX: SPLP, SPLPP), a diversified global holding company, has qualified to trade on the OTCQX® Best Market. Steel Partners Holdings LP previously traded on the New York Stock Exchange. Steel Partners Holdings L.P.’s common and series A preferred units begin trading today on OTCQX under the symbols “SPLP” and “SPLPP”, respectively. U.S. investors can find current f...

 PRESS RELEASE

OTC Markets Group Welcomes Parks! America, Inc. to OTCQX

OTC Markets Group Welcomes Parks! America, Inc. to OTCQX NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: PRKA), owner and operator of three regional safari parks, has qualified to trade on the OTCQX® Best Market. Parks! America, Inc. upgraded to OTCQX from the Pink® market. Parks! America, Inc. begins trading today on OTCQX under the symbol “PRKA.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . The OTCQX Marke...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch